Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07556861 · ClinicalTrials.gov registry record · NA
A Study Of Senyo Health With Comorbid Alcohol Use Disorder Treatment In Bipolar Patients
A NA study, sponsored by Mayo Clinic.
- Not yet
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07556861: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT07556861 is a NA study that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07556861, a NA study, has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effectiveness of a digital integrated behavioral health (IBH) platform in improving substance use outcomes, including treatment retention and substance use frequency and severity in patients with Bipolar Disorder.
Interventions
- OTHER Senyo Health App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-05-16 |
| Est. Completion | 2029-01-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07556861
The ClinicalTrials.gov registry entry for NCT07556861 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Senyo Health App is the first listed.
NCT07556861 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07556861 about?
NCT07556861 is a clinical study titled "A Study Of Senyo Health With Comorbid Alcohol Use Disorder Treatment In Bipolar Patients". The purpose of this study is to examine the effectiveness of a digital integrated behavioral health (IBH) platform in improving substance use outcomes, including treatment retention and substance use frequency and severity in patients with Bipolar Disorder.
What is the current status of trial NCT07556861?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-05-16. Estimated completion is 2029-01-20.
What interventions are being tested in trial NCT07556861?
The interventions under investigation include: Senyo Health App (OTHER).
Who is sponsoring clinical trial NCT07556861?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.